Account-creators
1,040
edits
Jensflorian (talk | contribs) (→By age group: Update) |
Jensflorian (talk | contribs) (Minor rearrangement) |
||
(6 intermediate revisions by the same user not shown) | |||
Line 93: | Line 93: | ||
* [[Olfactory neuroblastoma]]. | * [[Olfactory neuroblastoma]]. | ||
* [[Endolymphatic sac tumour]]. | * [[Endolymphatic sac tumour]]. | ||
===Primary versus secondary=== | ===Primary versus secondary=== | ||
Line 116: | Line 108: | ||
[[Lymphoma]]: | [[Lymphoma]]: | ||
*Primary CNS Lymphoma (PCNSL) is usu. a diffuse large B-cell lymphoma. | |||
*Large (lymphoid) cells, ergo usu. not a difficult diagnosis. | *Large (lymphoid) cells, ergo usu. not a difficult diagnosis. | ||
**~2x size of resting lymphocyte, nucleoli. | **~2x size of resting lymphocyte, nucleoli. | ||
Line 121: | Line 114: | ||
====Secondary==== | ====Secondary==== | ||
Carcinomas: | *Carcinomas: | ||
*Well-demarcated border between brain and lesion - '''key feature'''. | **Well-demarcated border between brain and lesion - '''key feature'''. | ||
*No cytoplasmic processes. | **No cytoplasmic processes. | ||
*Usu. have nuclear atypia of malignancy. | **Usu. have nuclear atypia of malignancy. | ||
**Nuclei often ~3-4x the size of a [[RBC]]. | **Nuclei often ~3-4x the size of a [[RBC]]. | ||
*+/-Glandular arrangement. | **+/-Glandular arrangement. | ||
*+/-Nucleoli. | **+/-Nucleoli. | ||
*Melanoma. | |||
*Secondary Lymphoma. | |||
*Sarcomas (rare). | |||
===By growth pattern=== | |||
====Infiltrative astrocytomas==== | |||
*[[Astrocytoma, IDH-mutant]]. | |||
*[[Glioblastoma]], IDH-wildtype. | |||
Notes: | |||
**Glial: "blends into brain"/gradual transition to non-tumour brain. | |||
====Non-infiltrative astrocytomas==== | |||
**[[Pilocytic astrocytoma]] | |||
**[[Pleomorphic xanthoastrocytoma]] | |||
**[[Subependymal giant cell astrocytoma]]. | |||
====Cystic tumours==== | |||
DDx:<ref>URL: [http://path.upmc.edu/cases/case320/dx.html http://path.upmc.edu/cases/case320/dx.html]. Accessed on: 14 January 2012.</ref> | |||
*[[Pilocytic astrocytoma]]. | |||
*[[Pleomorphic xanthoastrocytoma]]. | |||
*[[Ganglioglioma]]. | |||
*[[Hemangioblastoma]]. | |||
*[[Craniopharyngioma]].<ref>URL: [http://www.pathologyoutlines.com/Cnstumor.html#cystsgeneral http://www.pathologyoutlines.com/Cnstumor.html#cystsgeneral]. Accessed on: 14 January 2012.</ref> | |||
Notes: | |||
**Non-glial: no radiating glial processes. | |||
*Rosenthal fibres within the tumour... often seen in [[pilocytic astrocytoma]]. | |||
**Rosenthal fibres may be seen around a (very) slow growing tumour and represent a reactive process. | |||
*Inflammatory cells and macrophages should prompt consideration of an alternate diagnosis (e.g. [[cerebral infarct]], [[multiple sclerosis]]) - esp. if this is a primary lesion.<ref>URL: [http://path.upmc.edu/cases/case79/dx.html http://path.upmc.edu/cases/case79/dx.html]. Accessed on: 2 January 2012.</ref> | |||
====Grading==== | |||
Nuclear pleomorphism present: | |||
*At least grade II (diffuse astrocytoma). | |||
Mitotic figures present: | |||
*At least grade III (anaplastic astrocytoma). | |||
Microvascular proliferation ''or'' necrosis with pseudopalisading tumour cells: | |||
*Grade IV (glioblastoma [[AKA]] glioblastoma multiforme). | |||
Notes: | |||
*Pseudopalisading tumour cells = high tumour cell density adjacent to regions of necrosis; palisade = a fence of poles forming a defensive barrier or fortification. | |||
*WHO Grading is currently based on expected biologiocal behaviour without treatment. | |||
**Grading does not reflect molecular divergent groups within a tumor class or response to therapy (Currently controversies in grading for IDH-mutant astrocytoma vs. IDH-wildtype astrocytoma).<ref>{{Cite journal | last1 = Louis | first1 = DN. | last2 = von Deimling | first2 = A. | title = Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare. | journal = Acta Neuropathol | volume = | issue = | pages = | month = Aug | year = 2017 | doi = 10.1007/s00401-017-1765-z | PMID = 28801693 }}</ref> | |||
===By IHC=== | |||
*GFAP - should stain cytoplasm of tumour cells and the perikaryon (nuclear membrane) of most [[Astrocytoma]]s. | |||
*[[IDH-1]](R132H) (isocitrate dehydrogenase 1) in [[Astrocytoma, IDH-mutant]].<ref name=pmid19228619>{{cite journal |author=Yan H, Parsons DW, Jin G, ''et al.'' |title=IDH1 and IDH2 mutations in gliomas |journal=N. Engl. J. Med. |volume=360 |issue=8 |pages=765–73 |year=2009 |month=February |pmid=19228619 |pmc=2820383 |doi=10.1056/NEJMoa0808710 |url=}}</ref><ref name=pmid20975057>{{cite journal |author=Houillier C, Wang X, Kaloshi G, ''et al.'' |title=IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas |journal=Neurology |volume=75 |issue=17 |pages=1560–6 |year=2010 |month=October |pmid=20975057 |doi=10.1212/WNL.0b013e3181f96282 |url=}}</ref> | |||
*[[H3F3A|H3F3A K27M]] in [[Diffuse midline glioma, H3 K27-altered]]. | |||
*[[ATRX]] -ve in [[Astrocytoma, IDH-mutant]] or [[Diffuse hemispheric glioma, H3 G34-mutant]]. | |||
*[[CD20]] in PCNSL. | |||
*Cytokeratins in Carcinoma brain metastases, Plexus choroid tumours, [[AT/RT]], [[Papillary tumour of the pineal region]], [[Craniopharyngioma]]. | |||
*[[EMA]] in [[Meningioma]] and carcinoma brain metastases. | |||
*PrgR in [[Meningioma]] and carcinoma metastases. | |||
*[[Synaptophysin]] in glioneuronal tumours and Pituitary adenoma and embryonal tumours. | |||
===Common neuropathology tumours in a table=== | ===Common neuropathology tumours in a table=== | ||
Line 152: | Line 202: | ||
|variable | |variable | ||
|missed lesion / close to a lesion; non-specific pathologic process - need more tissue | |missed lesion / close to a lesion; non-specific pathologic process - need more tissue | ||
| | |GFAP | ||
|[[Image:Reactive_astrocytes_-_lfb_-_high_mag.jpg|thumb|center|150px|Reactive astrocytes. (WC)]] | |[[Image:Reactive_astrocytes_-_lfb_-_high_mag.jpg|thumb|center|150px|Reactive astrocytes. (WC)]] | ||
|- | |- | ||
Line 160: | Line 210: | ||
|old or young | |old or young | ||
|need frozen section to Dx, DDx: [[meningioma]] | |need frozen section to Dx, DDx: [[meningioma]] | ||
|S100 | |S100, SOX10 | ||
|[[Image:Schwannoma_-_Antoni_A_and_B_-_very_high_mag.jpg|thumb|center|150px|Schwannoma. (WC)]] | |[[Image:Schwannoma_-_Antoni_A_and_B_-_very_high_mag.jpg|thumb|center|150px|Schwannoma. (WC)]] | ||
|- | |- | ||
Line 200: | Line 250: | ||
{{Main|Brain metastasis}} | {{Main|Brain metastasis}} | ||
===Molecular=== | ===Molecular=== | ||
Line 290: | Line 265: | ||
* [[Glioblastoma]], IDH-wildtype. | * [[Glioblastoma]], IDH-wildtype. | ||
** [[Gliosarcoma]] (a glioblastoma subtype) | ** [[Gliosarcoma]] (a glioblastoma subtype) | ||
Features:<ref name=pmid>{{cite journal |author=Rong Y, Durden DL, Van Meir EG, Brat DJ |title='Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis |journal=J. Neuropathol. Exp. Neurol. |volume=65 |issue=6 |pages=529–39 |year=2006 |month=June |pmid=16783163 |doi= |url=}}</ref><ref>[http://dictionary.reference.com/browse/palisading http://dictionary.reference.com/browse/palisading]</ref> | |||
*Glial processes - '''key feature'''. | |||
**Thin stringy cytoplasmic processes - best seen at high power in less cellular areas. | |||
*No Rosenthal fibres within the tumour itself. | |||
Images: | |||
*[http://moon.ouhsc.edu/kfung/jty1/opaq/PathQuiz/N0A002-PQ01-M.htm Endothelial proliferation in a GBM (ouhsc.edu)]. | |||
*[http://moon.ouhsc.edu/kfung/jty1/neurotest/Q05-Ans.htm Endothelial proliferation (ouhse.edu)]. | |||
*[http://path.upmc.edu/cases/case368.html Gemistocytic astrocytoma - several images (upmc.edu)]. | |||
Depreceated: | Depreceated: |